Treatment of Group B Streptococcus Urinary Tract Infection
First-Line Treatment Recommendation
For non-pregnant adults with symptomatic GBS UTI, treat with ampicillin 500 mg orally every 8 hours for 3-7 days, or amoxicillin 500 mg orally every 8 hours as an equally effective alternative. 1, 2
Critical Distinction: Pregnancy Status Determines Management
Pregnant vs. Non-Pregnant Patients:
Pregnant women: Any concentration of GBS bacteriuria (regardless of CFU count or symptoms) mandates both immediate treatment of the UTI AND intrapartum antibiotic prophylaxis during labor with penicillin G 5 million units IV initially, then 2.5-3.0 million units IV every 4 hours until delivery. 1, 2, 3
Non-pregnant adults: Treat only if symptomatic or if bacteriuria is ≥50,000 CFU/mL with abnormal urinalysis. Asymptomatic bacteriuria in non-pregnant patients should NOT be treated. 1, 4
This distinction is critical because the CDC guidelines for universal GBS treatment apply specifically to prevent neonatal disease and do not apply to non-pregnant individuals. 4
Treatment Algorithm by Clinical Severity
Uncomplicated UTI (non-pregnant):
- Ampicillin 500 mg PO every 8 hours for 3-7 days 1, 2
- Alternative: Amoxicillin 500 mg PO every 8 hours for 3-7 days 1, 2
- All GBS strains remain fully sensitive to penicillin and ampicillin 5
Complicated UTI or Severe Infection:
- Escalate to ampicillin 18-30 g/day IV in divided doses 1, 2
- Alternative: Penicillin G 5 million units IV initially, then 2.5 million units IV every 4 hours 1
- Consider initial IV therapy with ampicillin 2 g IV every 4-6 hours, then transition to oral therapy once clinically stable 4
- Duration: 5-7 days for complicated UTI, 10-14 days for severe infections or bacteremia 1, 2
Men with possible prostatitis:
- Extend treatment duration to 14 days to ensure adequate coverage 4
Penicillin-Allergic Patients
Non-severe penicillin allergy:
Severe penicillin allergy:
- Clindamycin 900 mg IV every 8 hours OR 300-450 mg PO every 6-8 hours 2, 4
- Critical caveat: Clindamycin resistance is extremely high (77.34% in recent studies), so susceptibility testing is mandatory before use. 2, 5
- Vancomycin may be considered for severe infections with significant beta-lactam allergies 2
Essential Clinical Considerations
Obtain urine culture before treatment:
- Confirm diagnosis with culture showing ≥50,000 CFU/mL 1, 2
- Significant bacteriuria is defined as ≥50,000 CFU/mL of a single urinary pathogen 1, 2
Distinguish colonization from infection:
- Asymptomatic bacteriuria in non-pregnant patients should NOT be treated to prevent antibiotic resistance 1, 4
- Treatment of asymptomatic bacteriuria leads to unnecessary antibiotic exposure, resistance development, and potential adverse effects without clinical benefit 4
Pregnancy-specific management:
- Women with documented GBS bacteriuria in pregnancy should NOT be re-screened in the third trimester, as they are presumed colonized 3
- Fluoroquinolones must be avoided in pregnant patients 2
Common Pitfalls to Avoid
Underdosing or premature discontinuation:
- Leads to treatment failure and recurrence 1
- Ensure full course completion based on infection severity
Using clindamycin without susceptibility testing:
- High resistance rates (77.34%) make empiric use dangerous 1, 5
- Always confirm susceptibility before prescribing
Failing to provide intrapartum prophylaxis in pregnancy:
- Any GBS bacteriuria during pregnancy requires intrapartum prophylaxis to prevent neonatal mortality 1, 3
Treating asymptomatic bacteriuria in non-pregnant patients:
- This promotes antibiotic resistance without clinical benefit 1, 4
- Only treat symptomatic infections or significant bacteriuria with abnormal urinalysis
Overlooking complicated infections:
- GBS can cause rare but serious complications including abdominopelvic abscesses, particularly in diabetic patients 6
- Consider imaging if severe abdominal/pelvic pain accompanies UTI symptoms